ReviewOpen access rheumatology : research and reviews2026
Neuropsychiatric Systemic Lupus Erythematosus in Children: A Scoping Review.
Review in Open access rheumatology : research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) presents significant diagnostic and therapeutic challenges, particularly in childhood-onset SLE (cSLE), as there is limited pediatric-specific evidence, lack of specific diagnostic tests, and heavy reliance on adult data. This scoping review, the first dedicated specifically to the pediatric population, aims to evaluate the current literature on NPSLE in cSLE (cNPSLE), grade the level of evidence, and identify knowledge gaps in knowledge related to its manifestations, diagnosis, predictors, treatment and outcomes. Methods: A search was performed in MEDLINE, Embase, Cochrane, and PsycINFO (PRISMA diagram). Articles were screened in Covidence. Clinical trials, systematic reviews, cohort, case-control and cross-sectional studies published between 2000 and 2023, involving patients aged ≤18 years diagnosed with NPSLE, and with original manuscript available in English were included. Five reviewers performed abstract and full-text screening. Eight reviewers performed full-text extraction. Quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Results: Sixty-five articles met eligibility criteria. Prevalence of cNPSLE ranged from 4.4% to 99.8%. Sociodemographic information was based on individual study metrics. Predictive factors for cNPSLE development were the most studied but were contradictory from study to study. Most frequent clinical manifestations were cognitive dysfunction, headaches and seizures. Common imaging findings were cerebral and cerebellar volume loss and white matter hyperintensities, though up to 50% of patients with active cNPSLE had normal imaging in 4 included studies. No pharmacologic clinical trials for cNPSLE are published. Outcomes from cNPSLE were variable. Conclusion: This scoping review highlights the scarcity of articles on cNPSLE and identifies significant knowledge gaps. The 1999 ACR NPSLE case definitions, while providing a framework for classifying NPSLE, are not formally validated in children, resulting in heterogeneity in existing cNPSLE research and diagnostic criteria. Per the GRADE methodology, most studies were retrospective, single center, with low quality of evidence. The range in prevalence and frequency of cNPSLE manifestations highlights the lack of consensus in cNPSLE definition and evaluation as well as the heterogeneity of study populations. We highlight the need for high quality studies and consensus regarding cNPSLE definition, diagnosis, and management - a critical first step to guide the development of an international, multi-center prioritized research agenda for cNPSLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.